The move comes months after the agency expanded the drug’s emergency use authorization to also include children below 12 years of age weighing at least 3.5 kilograms.
The Food and Drug Administration’s (FDA) decision makes the drug the first approved COVID-19 treatment for children less than 12 years of age, the agency said.
Unvaccinated people increase risk of COVID-19 infection among vaccinated: new study
Judge holds Donald Trump in contempt for not complying with subpoena
The approval is applicable to children who are hospitalized, or have mild-to-moderate disease and are at high risk of severe COVID-19.
(Reporting by Manas Mishra in Bengaluru; Editing by Aditya Soni)
© 2022 Reuters